ABCL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ABCL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
AbCellera Biologics's Loans Receivable for the quarter that ended in Sep. 2024 was $0.00 Mil.
The historical data trend for AbCellera Biologics's Loans Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbCellera Biologics Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Loans Receivable | Get a 7-Day Free Trial | - | - | - | - | - |
AbCellera Biologics Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Loans Receivable | Get a 7-Day Free Trial | - | - | - | - | - |
Loans Receivable are the funds that a company has lent but have not yet been repaid.
Thank you for viewing the detailed overview of AbCellera Biologics's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
Thermopylae Holdings Ltd. | 10 percent owner | 2215 YUKON STREET, VANCOUVER A1 V5Y 0A1 |
John S. Montalbano | director | C/O ABCELLERA BIOLOGICS INC., 2215 YUKON STREET, VANCOUVER A1 V5Y 0A1 |
Michael R Hayden | director | C/O ASPREVA PHARMACEUTICALS CORPORATION, 1203-4464 MARKHAM STREET, VICTORIA A1 V8Z 7X8 |
Veronique Lecault | director, officer: Chief Operating Officer | C/O ABCELLERA BIOLOGICS INC., 2215 YUKON STREET, VANCOUVER A1 V5Y 0A1 |
Andrew Booth | officer: Chief Financial Officer | C/O ABCELLERA BIOLOGICS INC., 2215 YUKON STREET, VANCOUVER A1 V5Y 0A1 |
Andrew Lo | director | C/O ALPHASIMPLEX GROUP, LLC, ONE CAMBRIDGE CENTER, 9TH FLOOR, CAMBRIDGE MA 02142 |
John Hamer | director, 10 percent owner | PO BOX 14528, RESEARCH TRIANGLE PARK NC 27709-4528 |
Ester Falconer | officer: Chief Technology Officer | C/O ABCELLERA BIOLOGICS INC., 2215 YUKON STREET, VANCOUVER A1 V5Y 0A1 |
Hansen Carl L. G. | director, 10 percent owner, officer: Chief Executive Officer | C/O ABCELLERA BIOLOGICS INC., 2215 YUKON STREET, VANCOUVER A1 V5Y 0A1 |
Tryn Stimart | officer: Chief Legal Officer | C/O ABCELLERA BIOLOGICS INC., 2215 YUKON STREET, VANCOUVER A1 V5Y 0A1 |
Peter Thiel | director | 9200 SUNSET BOULEVARD, SUITE 1110, WEST HOLLYWOOD CA 90069 |
Dcvc Bio, L.p. | 10 percent owner | 317 UNIVERSITY AVENUE, SUITE 200, PALO ALTO CA 94301 |
Dcvc Bio Gp, Llc | 10 percent owner | 270 UNIVERSITY AVENUE, PALO ALTO CA 94301 |
Zachary Bogue | 10 percent owner | 270 UNIVERSITY AVENUE, PALO ALTO CA 94301 |
Matthew Ocko | 10 percent owner | 270 UNIVERSITY AVENUE, PALO ALTO CA 94301 |
From GuruFocus
By Business Wire • 05-01-2024
By GuruFocus Research • 08-08-2024
By Business Wire • 04-08-2024
By Business Wire • 05-28-2024
By GuruFocus Research • 05-07-2024
By Business Wire • 11-21-2024
By Business Wire • 10-04-2024
By Business Wire • 03-19-2024
By Business Wire • 11-07-2024
By Business Wire • 06-25-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.